Q9CYC6
Gene name |
Dcp2 |
Protein name |
m7GpppN-mRNA hydrolase |
Names |
mRNA-decapping enzyme 2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:70640 |
EC number |
3.6.1.62: In phosphorus-containing anhydrides |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9CYC6
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9CYC6-F1 | Predicted | AlphaFoldDB |
21 variants for Q9CYC6
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389479166 | 26 | S>R | No | EVA | |
| rs3389501712 | 38 | Q>H | No | EVA | |
| rs3389502979 | 58 | P>L | No | EVA | |
| rs3411602252 | 80 | G>D | No | EVA | |
| rs3389494925 | 84 | E>D | No | EVA | |
| rs3408121096 | 120 | A>G | No | EVA | |
| rs3408399200 | 121 | K>E | No | EVA | |
| rs3389501715 | 150 | G>V | No | EVA | |
| rs3389459085 | 184 | T>S | No | EVA | |
| rs3408121093 | 191 | R>I | No | EVA | |
| rs3389494894 | 191 | R>S | No | EVA | |
| rs3389468598 | 201 | S>A | No | EVA | |
| rs3389468567 | 245 | D>E | No | EVA | |
| rs30220684 | 300 | S>P | No | EVA | |
| rs3408499233 | 345 | K>Q | No | EVA | |
| rs3408473713 | 347 | Q>H | No | EVA | |
| rs3408499114 | 348 | N>K | No | EVA | |
| rs3408427519 | 349 | P>L | No | EVA | |
| rs3389494907 | 353 | C>R | No | EVA | |
| rs3389510012 | 392 | A>V | No | EVA | |
| rs266140979 | 405 | A>T | No | EVA |
No associated diseases with Q9CYC6
5 regional properties for Q9CYC6
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Tyrosine-specific protein phosphatases domain | 344 - 406 | IPR000387 |
| domain | Protein-tyrosine phosphatase, catalytic | 323 - 471 | IPR003595 |
| domain | GRAM domain | 29 - 143 | IPR004182 |
| domain | Myotubularin-like, phosphatase domain | 151 - 538 | IPR010569 |
| active_site | Protein-tyrosine phosphatase, active site | 373 - 383 | IPR016130 |
Functions
| Description | ||
|---|---|---|
| EC Number | 3.6.1.62 | In phosphorus-containing anhydrides |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
6 GO annotations of cellular component
| Name | Definition |
|---|---|
| cell junction | A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella. |
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytoplasmic ribonucleoprotein granule | A ribonucleoprotein granule located in the cytoplasm. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| P-body | A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing. |
| RISC complex | A ribonucleoprotein complex that contains members of the Argonaute family of proteins, small interfering RNAs (siRNAs) or microRNAs (miRNAs), and miRNA or siRNA-complementary mRNAs, in addition to a number of accessory factors. The RISC complex is involved in posttranscriptional repression of gene expression through downregulation of translation or induction of mRNA degradation. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| 5'-3' exoribonuclease activity | Catalysis of the sequential cleavage of mononucleotides from a free 5' terminus of an RNA molecule. |
| m7G(5')pppN diphosphatase activity | Catalysis of the reaction: 7-methylguanosine 5'-triphospho-5'-polynucleotide + H2O = 7-methylguanosine 5'-phosphate + polynucleotide. |
| manganese ion binding | Binding to a manganese ion (Mn). |
| RNA binding | Binding to an RNA molecule or a portion thereof. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| deadenylation-dependent decapping of nuclear-transcribed mRNA | Cleavage of the 5'-cap of a nuclear mRNA triggered by shortening of the poly(A) tail to below a minimum functional length. |
| histone mRNA catabolic process | The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA). |
| mRNA catabolic process | The chemical reactions and pathways resulting in the breakdown of mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes. |
| negative regulation of telomere maintenance via telomerase | Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of telomeric repeats by telomerase. |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins. |
| regulation of mRNA stability | Any process that modulates the propensity of mRNA molecules to degradation. Includes processes that both stabilize and destabilize mRNAs. |
| regulation of telomerase RNA localization to Cajal body | Any process that modulates the frequency, rate or extent of telomerase RNA localization to Cajal body. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEPKRLEIPG | SVLDDLCSRF | ILHIPSEERD | NAIRVCFQIE | LAHWFYLDFY | MQNTPGLPQC |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GIRDFAKAVF | SHCPFLLPQG | EDVEKILDEW | KEYKMGVPTY | GAIILDETLE | NVLLVQGYLA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KSGWGFPKGK | VNKEEAPHDC | AAREVFEETG | FDIKDYICKD | DYIELRINDQ | LARLYIIPGV |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PKDTKFNPKT | RREIRNIEWF | SIEKLPCHRN | DMTPKSKLGL | APNKFFMAIP | FIRPLRDWLS |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RRFGDSSDSD | NGFSSAGSTP | ARPTVEKLSR | TKFRHSQQLF | PEGSPSDQWV | KHRQPLQQKS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| HSNHGEVSDL | LKAKNQNMRG | NGRKQYQDSP | NQKKRANGVH | GQPAKQQNPL | VKCEKKLHPR |
| 370 | 380 | 390 | 400 | 410 | 420 |
| KLQDNFETDA | TCDLPCSGEE | PSVEHAEGHS | VACNGHCKFP | FSSRAFLSFK | FDQNAIMKIL |
| DL |